Cited by 66Angiogenesis and VEGF in CancerNeurogenesis and neuroplasticity mechanismsBarrier Structure and Function Studies

Attenuation of brain response to vascular endothelial growth factor-mediated angiogenesis and neurogenesis in aged mice

Open access
Gao, Peng, Shen, Fanxia, Gabriel, Rodney Allanigue, Law, David, Yang, Ethan Yibo, Yang, Guo-Yuan, Young, William L., Su, Hua·2009·Stroke

Abstract

Background and Purpose— Alterations of neuroangiogenic response play important roles in the development of aging-related neurodisorders and affect gene-based therapies. We tested brain response to vascular endothelial growth factor (VEGF) in aged mice. Methods— Adeno-associated viral vector (AAV)-VEGF, an adeno-associated viral vector expressing VEGF, was injected into the brain of 3-, 12-, and 24-month-old mice. AAV-LacZ-injected mice were used as controls (n=6). Before euthanasia at 6 weeks after vector injection, the mice were intraperitoneally injected with 5-bromodeoxyuridine for 3 consecutive days. The vascular density and the number of neuroprogenitors were analyzed. Results— Injection of AAV-VEGF increased the vascular density in the brain of 3-, 12-, and 24-month-old mice by 22%±7% (AAV-VEGF: 320±15 per 10× field versus AAV-LacZ: 263±8, P <0.05), 20%±8 (AAV-VEGF: 300±9 versus AAV-LacZ: 250±11, P <0.05), and 7%±16% (AAV-VEGF: 257±27 versus AAV-LacZ: 236±13, P =0.283), respectively. There were more VEGF receptor-positive neuroprogenitors in the subventricular zone of AAV-VEGF-injected 3- (22±2) and 12-month-old mice (21±5) than that of 24-month-old mice (7±1). More 5-bromodeoxyuridine-positive endothelial cells and neuroprogenitors were detected around the injection site and subventricular zone of 3- (13±4) and 12-month-old mice (14±5) than that of 24-month-old mice (1±1). VEGF receptor 2 was upregulated in AAV-VEGF-injected brains of 3- and 12-month-old mice, but not in 24-month-old mice. Conclusion— The angiogenic and neurogenic response to VEGF stimulation is attenuated in the aged mouse brain, which may be due to reduced VEGF receptor activity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/strokeaha.109.561050

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 27 · Cited by 66

Authors
Gao, P., Shen, F., Gabriel, R. A., Law, D., Yang, E. Y., Yang, G.-Y., Young, W. L., & Su, H.
Affiliations
University of California, San Francisco (US)
Venue
Stroke
Published
2009-11
Volume
40
Issue
11
Pages
3596-3600
ISSN
  • 0039-2499 (ISSN-L)
  • 1524-4628
OpenAlex
W2160857742
Cited by
66
References
27
Citations by year
2026: 7 · 2025: 1 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 5 · 2017: 1 · 2015: 8 · 2014: 5 · 2013: 6 · 2012: 8
FWCI
2.00
Type
journal article
Language
en
Open access
Locations
  • Stroke (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • American Heart Association
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (P01NS044155, R01NS027713)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
vascular endothelial growth factor, angiogenesis, neurogenesis, brain aging, adeno-associated virus vectors, VEGF receptor 2, subventricular zone, vessel density, endothelial cells, aged mice, gene therapy, BrdU labeling, neurodegenerative diseases
MeSH terms
Dependovirus, Aging, Animals, Brain Chemistry, Gene Expression Regulation, Genetic Vectors, Mice, Inbred C57BL, Genetic Therapy, Neovascularization, Physiologic, Vascular Endothelial Growth Factor A, Mice, Neurogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review